Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.

H Abdel-Nabi, RJ Doerr, DM Lamonica, VR Cronin… - Radiology, 1998 - pubs.rsna.org
PURPOSE: To evaluate the diagnostic usefulness of positron emission tomography (PET)
with fluorine-18 fluorodeoxyglucose (FDG) in patients with primary colorectal carcinomas. …

18F-FDG imaging: pitfalls and artifacts

…, ES Crawford, HA Nabi - Journal of nuclear …, 2005 - Soc Nuclear Med
18 F-FDG PET is emerging as a useful tool in the staging and restaging of many malignant
neoplasms, such as lymphoma, lung cancer, colorectal cancer, head and neck cancer, breast …

[HTML][HTML] Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules.

M Khalaf, H Abdel-Nabi, J Baker, Y Shao… - Journal of hematology & …, 2008 - Springer
Abstract The most common semiquantitative method of evaluation of pulmonary lesions using
18 F-FDG PET is FDG standardized uptake value (SUV). An SUV cutoff of 2.5 or greater …

Immunoscintigraphy of prostatic cancer: Preliminary results with 111in‐labeled monoclonal antibody 7E11‐C5.3 (CYT‐356)

…, G Purnell, I Tyson, A Heal, H AbdelNabi… - The …, 1991 - Wiley Online Library
A phase 1 study was conducted with the investigational immunoscintigraphic agent, 111 In‐CYT‐356,
a radiolabeled, site‐specific immunoconjugate of monoclonal antibody 7E11‐C5.3…

Radiolabeled antibody imaging in the management of colorectal cancer results of a multicenter clinical study

RJ DOERR, H ABDEL-NABI, D KRAG… - Annals of …, 1991 - journals.lww.com
Materials and Methods Purified, cell culture-produced monoclonal antibody B72. 3 was
obtained from Celltech Ltd.(Berkshire, United Kingdom) and site specifically conjugated with the …

Increased tumor uptake of chemotherapeutics and improved chemoresponse by novel non-anticoagulant low molecular weight heparin

PG Phillips, M Yalcin, H Cui, H Abdel-Nabi… - Anticancer …, 2011 - ar.iiarjournals.org
Background: Recent prospective clinical trials of low molecular weight heparins (LMWHs)
have demonstrated that these agents may provide significant advantages in terms of …

Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT.

BD Collier, H Abdel-Nabi, RJ Doerr, SJ Harwood… - Radiology, 1992 - pubs.rsna.org
Immunoscintigraphy performed after intravenous administration of indium-111-labeled CYT-103,
an immunoconjugate of monoclonal antibody B72.3, was evaluated in patients with …

[HTML][HTML] Current status of cancer immunodetection with radiolabeled human monoclonal antibodies

R De Jager, H Abdel-Nabi, A Serafini, A Pecking… - Seminars in nuclear …, 1993 - Elsevier
The use of radiolabeled murine monoclonal antibodies (MoAbs) for cancer immunodetection
has been limited by the development of human antimouse antibodies (HAMA). Human …

[PDF][PDF] Procedure guideline for breast scintigraphy

…, PJ Peller, HH Abdel-Nabi - Journal of Nuclear …, 1999 - Soc Nuclear Med
A. Patient Preparation 1. No special preparation for the test is needed; however, a thorough
explanation of the test should be provided by the technologist or physician. 2. The patient …

Tumor immunolocalization using 124I-iodine-labeled JAA-F11 antibody to Thomsen–Friedenreich alpha-linked antigen

…, J Yan, S Koury, M Sajjad, HH Abdel-Nabi… - Applied Radiation and …, 2008 - Elsevier
Clinical immunolocalization has been attempted by others with an anti-Thomsen–Friedenreich
antigen (TF-Ag) mAb that bound both alpha- and beta-linked TF-Ag. In this report, 124 I-…